Market cap of BioAmber Inc.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers primarily in the United States and Canada. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company's bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol and tetrahydrofuran used in elastomers, engineering plastics, shoe soles, spandex, and solvents; succinic acid based polyesters for use in automotive interiors, fibers and non-wovens, food packaging, plastic bags and cups, and organic composite boards; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine used in carpets, engineering plastics, textiles and fibers, films, and polyurethanes. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.
|PFNX Pfenex Inc.||NYSEMKT > Health Care > Major Pharmaceuticals||-255.87%|
|ADMA ADMA Biologics Inc||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||-250.87%|
|OHGI One Horizon Group, Inc.||NASDAQ > Public Utilities > Telecommunications Equipment||-247.78%|
|JAG Jagged Peak Energy Inc.||NYSE > Energy > Oil & Gas Production||-246.94%|
|AVIR Aviragen Therapeutics, Inc.||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||-243.59%|
|PRAN Prana Biotechnology Ltd||NASDAQ > Health Care > Major Pharmaceuticals||-239.05%|
|BIOA BioAmber Inc.||NYSE > Basic Industries > Major Chemicals||-238.42%|
|ASG Liberty All-Star Growth Fund, Inc.||NYSE > Finance > Closed-End Fund - Equity||2,321.85%|
|WMIH WMIH Corp.||NASDAQ > Finance > Finance: Consumer Services||2,450.53%|
|INVT Inventergy Global, Inc.||NASDAQ > Technology > Telecom Services - Domestic||2,494.79%|
|LBRDA Liberty Broadband Corporation||NASDAQ > Consumer Services > Television Services||15,533.66%|
|LBRDK Liberty Broadband Corporation||NASDAQ > Consumer Services > Television Services||15,533.66%|
|CNCE Concert Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||122,824.66%|